Skip to content
Chr. Hansen showcases its newest probiotic strains at Vitafoods 2010

Press release -

Chr. Hansen showcases its newest probiotic strains at Vitafoods 2010

At this year’s Vitafoods trade show for the nutraceutical industry Chr. Hansen will be focusing on exhibiting its newest probiotic strains for optimized gastrointestinal and immune health.

"We will bring our entire portfolio of probiotic solutions for human health and nutrition to Vitafoods so visitors to our booth will undoubtedly find something of interest to them whether they represent the dietary supplement industry, the infant formula industry or the pharmaceutical industry," says Charlotte Beyerholm, Marketing Manager, Human Health & Nutrition, Chr. Hansen.

Newest strains in the Probio-Tec® range

"However, Vitafoods attendees will notice that we have chosen Vitafoods as the occasion to showcase Lactobacillus fermentum PCC® and Lactobacillus F19®, the two most recent extensions to our Probio-Tec® range of probiotic strains with documented effect," says Beyerholm. "Furthermore, we are looking forward to be exhibiting our chewable probiotic tablets in three exciting flavors."

Chr. Hansen recently secured the rights to market the patented probiotic strain Lactobacillus fermentum PCC® which is owned by Australian Probiomics Ltd. "PCC® is a very promising strain within immune health," says Sune Schmoelker, Commercial Development Director, Human Health & Nutrition, Chr. Hansen. "Several clinical studies in various indication areas have been conducted and PCC® has shown to be effective as an adjuvant to flu vaccine, in supporting the immune response in athletes, and in relation to atopic dermatitis."

Chr. Hansen has produced and sold F19® for Arla Foods since acquiring Arla Foods' subsidiary Medipharm AB. More than 20 human studies and 40 published articles document F19®'s health benefits. "F19® shows excellent survivability in the intestines and it has been used for more than 15 years for gastrointestinal health. It is a stable and safe probiotic strain - also for children down to four months", Schmoelker concludes.

Convenience and good taste

“The chewable probiotic tablets are intended for all age groups but particularly suitable for children,” says Charlotte Beyerholm. “This convenient way to easily consume the beneficial probiotic cultures is a much requested alternative to the traditional tablet or capsule. Today’s consumers appreciate to be able to choose among a number of different dosage formats. The chewable tablet format and the flavor assortment represent an opportunity for our customers to differentiate their products."

Vitafoods 2010 takes place in Geneva, Switzerland, May 18-20. Meet Chr. Hansen at booth no. 518 and at the Supplier Seminar on May 19.


Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.


Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970 Hoersholm